Allogene Therapeutics
ALLO
ALLO
168 hedge funds and large institutions have $686M invested in Allogene Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
-23
Holders Change %
-12.04%
% of All Funds
2.71%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
67
Reduced
55
Closed
40
Calls
$621K
Puts
$400K
Net Calls
+$221K
Net Calls Change
-$97K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$57.7M |
| 2 |
2
Millennium Management
New York
|
$20.6M |
| 3 |
ECM
3
ExodusPoint Capital Management
New York
|
$7.29M |
| 4 |
4
Two Sigma Investments
New York
|
$10.1M |
| 5 |
5
Two Sigma Advisers
New York
|
$6.04M |
